Text Size

Primary Rituximab and Maintenance

This study has been completed.
Sponsor:
Collaborators:
HOVON - Dutch Haemato-Oncology Association
German Low Grade Lymphoma Study Group
OSHO
Australasian Leukaemia and Lymphoma Group
Institute of Cancer Research, United Kingdom
Information provided by:
Lymphoma Study Association
ClinicalTrials.gov Identifier:
NCT00140582
First received: August 22, 2005
Last updated: January 27, 2009
Last verified: January 2009
History of Changes
No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
No publications provided by Lymphoma Study Association

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):